Marker Therapeutics, Inc.
MRKR
Last
$0.97
Day
+2.3%
1y
-9.5%
5y
-94.3%
52w
-61.4%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1233d
EMA 21
1.10
EMA 50
1.18
EMA 200
1.34
20d high
-27.5%
5y high
-94.5%
5y range
2th
Positions held
Your positionsMRKR isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$1.09
Stop
$0.83
Stop distance
14.6%
Target vs last
+12.2%
Fundamentals
| Market cap | $15.84M | Enterprise value | $4.51M | Trailing P/E | — | Forward P/E | -1.79 |
| PEG | — | Price / book | 1.30 | Beta | 1.53 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | -148.3% | Operating margin | -2.7% |
| Profit margin | -2.5% | ROE | -76.9% | ROA | -40.5% | Debt / equity | — |
| Current ratio | 6.03 | Free cash flow | -$6.23M | Analyst recommendation | none | Mean target | $7.87 |
| 52w high | $2.46 | 52w low | $0.84 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$1.8M | -$3.2M | -$1.7M | -$2.0M | -$4.0M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$1.9M | -$3.3M | -$1.9M | -$2.1M | -$4.3M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $3.3M | $0.0M | — |
| Op margin | — | — | -340.4% | — | — |
| Net income | -$12.2M | -$10.7M | -$8.2M | -$29.9M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$12.4M | -$11.1M | -$11.3M | -$19.8M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsMRKR · daily-22.1% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin